Long-term prognosis of asthma is good - A 12-year follow-up study. Influence of treatment

Journal of Asthma

Volumn 46, Issue 6, 2009, Pages 625-631

  Porpodis, Konstantinos ^a   Papakosta, Despina ^a   Manika, Katerina ^a   Kontakiotis, Theodoros ^a   Gaga, Mina ^b   Sichletidis, Lazaros ^a   Gioulekas, Dimitrios ^a  

^a G Papanikolaou Hospital   (Greece)

^b Hospital for Diseases of the Chest SOTIRIA   (Greece)

Author keywords

BHR; Bronchial asthma; Predictive factors; Prognosis; Rhinitis

Indexed keywords

ANTIHISTAMINIC AGENT; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; CHOLINERGIC RECEPTOR BLOCKING AGENT; CORTICOSTEROID; CROMOGLYCATE DISODIUM; METHACHOLINE; THEOPHYLLINE;

ADOLESCENT; ADULT; AGE; ARTICLE; ASTHMA; BRONCHUS HYPERREACTIVITY; BRONCHUS OBSTRUCTION; CHILD; CONTROLLED STUDY; DISEASE CLASSIFICATION; DISEASE DURATION; DISEASE SEVERITY; EOSINOPHIL COUNT; FAMILY HISTORY; FEMALE; FOLLOW UP; FORCED EXPIRATORY VOLUME; HUMAN; LONG TERM CARE; LUNG FUNCTION; MAJOR CLINICAL STUDY; MALE; MILD PERSISTENT ASTHMA; MODERATE PERSISTENT ASTHMA; PRESCHOOL CHILD; PRICK TEST; PROGNOSIS; QUESTIONNAIRE; RESPIRATORY TRACT INFECTION; RHINITIS; SCHOOL CHILD; SEVERE PERSISTENT ASTHMA; SEX DIFFERENCE; SKIN TEST; SMOKING; SPIROMETRY; TREATMENT OUTCOME;

ADMINISTRATION, INHALATION; ADOLESCENT; ADRENAL CORTEX HORMONES; ADULT; AGE FACTORS; ASTHMA; BRONCHIAL HYPERREACTIVITY; CHILD; COHORT STUDIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; LUNG; MALE; MIDDLE AGED; PROGNOSIS; RHINITIS; SEVERITY OF ILLNESS INDEX; SEX FACTORS; SMOKING; YOUNG ADULT;

EID: 68849106727     PISSN: 02770903     EISSN: 15324303     Source Type: Journal    
DOI: 10.1080/02770900903029796     Document Type: Article

References (44)

1. Viegi G, Annesi I, Mattelli G. Epidemiology of asthma. In Chung F, Fabbri LM, ed. Asthma. European Respiratory Monograph 2003(23). ERS Journals Ltd., UK 2003; 2-25.
2. Global strategy for asthma management and prevention. National Heart, Lung and Blood Institute. National Institute of Health. Bethesda,Maryland, USA. (2002) (www.ginasthma.com).
3. World Health Organization (WHO). Bronchial asthma. WHO Fact Sheet No 206. Revised January 2000.
4. Thomsen SF, Ulrik CS, Kyvik KO, et al. Risk factors for asthma in young adults: a co-twin control study. Allergy 2006; 61(2):229-233. (Pubitemid 43381835)
5. Polosa R, Al-Delaimy WK, Russo C, et al. Greater risk of incident asthma cases in adults with allergic rhinitis and effect of allergen immunotherapy: a retrospective cohort study. Respir Res 2005; 28(6):153. (Pubitemid 43020115)
6. Carolien I, Panhuysen IC, Vonk MJ, et al. Adult patients may outgrow their asthma (A 25-year follow-up study). Am J Respir Crit Care Med 1997; 155:1267-1272. (Pubitemid 27172769)
7. Suppli C, Backer V, Dirksen A. A 10 year follow up of 180 adults with bronchial asthma: factors important for the decline in lung function. Thorax 1992; 47:14-18.
8. Szefler SJ. The natural history of asthma and early intervention. J Allergy Clin Immunol 2002; 109(Suppl 6):549-553.
9. 1 is associated with risk of asthma attacks in long term follow-up. Chest 2004; 126(6):1875-1882.
10. Strachan DP, Butland BK, Anderson HR. Incidence and prognosis of asthma and wheezing illness from early childhood to age 33 in a national British cohort. Br Med J 1996; 312:1195-1199.
11. Halasz A, Cserhati E. The prognosis of Bronchial Asthma in childhood in Hungary: A long-term follow-up. J Asthma 2002; 39(8):693-699. (Pubitemid 36076442)
12. Roorda RJ, Gerritsen J, Van Aalderen WM, et al. Follow-up of asthma from childhood to adulthood: Influence of potential childhood risk factors on the outcome of pulmonary function and bronchial responsiveness in adulthood. J Allergy Clin Immunol 1994; 93:575-584. (Pubitemid 24105062)
13. Blair H. Natural history of childhood asthma (20-years follow-up). Arch Dis Child 1977; 52:613-619. (Pubitemid 8177239)
14. American Thoracic Society. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease (COPD) and asthma. Am Rev Respir Dis 1987; 136:225-244.
15. American Thoracic Society. Standardization of spirometry (1994 update). Am J Respir Crit Care Med 1995; 152:1107-1136.
16. Cockcroft DW. Bronchial inhalation tests I. Measurement of nonallergic bronchial responsiveness. Ann Allergy 1985; 4:527-534.
17. Chin S. Comparing and combining studies of bronchial responsiveness. Thorax 2002; 57:393-395.
18. Chin S. Methodology of bronchial responsiveness. Thorax 2002; 53(11):984.
19. Cockroft DW, Berscheid BA, Murdock KY. Measurement of responsiveness to inhaled histamine using FEV1: comparison of PC20 and threshold. Thorax 1983; 38:523-526.
20. O'Connor G, Sparrow D, Taylor D, et al. Analysis of dose-response curves to methacholine. Am Rev Respir Dis 1987; 136:1412-1417.
21. American Thoracic Society. Guidelines formethacholine and exercise challenge testing-1999. Am J Respir Crit Care Med 2000; 161:309-327.
22. Niemeijer NR, De Monchy JG. Age-dependency of sensitization to aeroallergens in asthmatics. Allergy 1992; 47:431-435.
23. Gioulekas D, Chatzigeorgiou G, Spieksma F. Allergenic pollen and pollinosis in northern Greece. In: D'Amato G, Spieksma FT, Bonini S, ed. Allergenic pollen and pollinosis in Europe. Melbourne, Paris, Berlin, Vienna: Blackwell Scientific Publications, 1991;167-171.
24. Girodet PO, Casset A, Magnan A, et al. IgE and respiratory disease. Rev Mal Respir 2005; 26(6):423-427.
25. Rothenberg MF. The eosinofils. Annu Rev Immunol 2006; 24:147-174.
26. Bel E.Clinical phenotypes of asthma. Curr Opin Pulm Med 2003; 10:44-50.
27. Papageorgiou N, Gaga M, Marossis C, et al. Prevalence of asthma and asthma-like symptoms in Athens, Greece. Respir Med 1997; 91(2):83-88. (Pubitemid 27107671)
28. The ENFUMOZA cross-sectional European multicentre study of the clinical phenotype of chronic severe asthma. The ENFUMOZA Study Group. Eur Respir J 2003; 22:470-477.
29. Borish L, Chipps B, Deniz Y, et al. For the TENOR Study Group. Total serum IgE levels in a large cohort of patients with severe or difficult-to-treat asthma. Ann Allergy Asthma Immunol 2005; 95:247-253.
30. Carolien I, Panhuysen IC, Vonk MJ, et al. Adult patients may outgrow their asthma (A 25-year follow-up study). Am J Respir Crit Care Med 1997; 155:1267-1272. (Pubitemid 27172769)
31. Mc Niicol KN, Williams HF. Spectrum of asthma in children. BMJ 1973; 4:7-11.
32. Ogilvie A. Asthma. A study in prognosis of 1000 patients. Thorax 1962; 17:183-189.
33. Skobeloff EM, Spivey WH, St Clair SS, Schoffstall JM. The influence of age and sex on asthma admissions. JAMA 1992; 268:3437-3440.
34. Lombardi C, Passalacqua G, Gargioni S, et al. The natural history of respiratory allergy: A follow-up study of 99 patients up to 10 years. Respir Med 2001; 95:9-12. (Pubitemid 32621980)
35. Grol MH, Gerritsen J, Vonk JM, et al. Risk factors for growth and decline of lung function in asthmatic individuals up to age 42 years (a 30-years follow-up study). Am J Respir Crit Care Med 1999; 160:1830-1837.
36. Holberg S, Enright P, Lebowits M, et al. Longitudinal analysis of the effects of smoking onset and cessation on pulmonary function. Am J Respir Crit Care Med 1994; 149:591-597. (Pubitemid 24082211)
37. Corren J. The impact of allergic rhinitis on bronchial asthma. J Allergy Clin Immunol 1998; 101:352-356. (Pubitemid 28160163)
38. Schayck CP, Dompeling CL, Herwaarden AM, et al. Interacting effects of atopy and bronchial hyperresponsiveness on the annual decline in lung function and the exacerbation rate in asthma. Am Rev Respir Dis 1991; 144:1297-1301.
39. Peat JK,Woolcock AJ,Cullen K. Rate of decline of lung function in subjects with asthma. Eur J Respir Dis 1987; 70:171-179.
40. Kelly WJW, Hudson I, Raven J, et al. Childhood asthma and adult lung function. Am Rev Respir Dis 1988; 138:26-30. (Pubitemid 18195519)
41. O'Byrne PM, Bisgaard H, Godard PP, et al. Budesonide/Formoterol combination therapy as both maintenance and reliever medication in asthma. Am J Respir Crit Care Med 2005; 171:129-136. (Pubitemid 40105411)
42. Rabe KF, Atienza T, Magyar P, et al. Effect of budesonide in combination with formoterol for reliever therapy in asthma exacerbations: a randomised controlled, double-blind study. Lancet 2006; 368:744-753. (Pubitemid 44279053)
43. Bousquet J, Boulet LP, Peters MJ, et al. Budesonide/formoterol for maintance and relief in uncontrolled asthma vs. high-dose salmeterol/ fluticasone. Respir Med 2007; 101:2347-2446. (Pubitemid 350010579)
44. Papi A, Canonica GW, Maestrelli P, et al. Rescue use of beclomethazone and albuterol in a single inhaler for mild asthma. N Engl J Med 2007; 356:2040-2052. (Pubitemid 46789894)